1,721,679 research outputs found

    Serous Cystic Neoplasms

    No full text
    Clear elements of understanding such uncommon entities Opinion of the main experts of the specific field Newest published literature evidence Uncommon tumors of the pancreas are of increasing interest for clinicians: cross imaging techniques development makes it possible to detect small lesions in the pancreatic gland of asymptomatic patients, and in the last decades a more detailed and specific pathological classification definitivelyopened an unexpected world of more or less rare pancreatic tumors. As a matter of fact, nowadays most surgical procedures deal with these so called uncommon pancreatic tumors such as cystic, endocrine and others unfrequent histotypes, and many patientsexperiencing an accidental discovery of this type of tumor need therefore a specialistic evaluation. The concept behind this volume is the need to give the correct clinical relevance to these “uncommon” tumors, that are ranked at the first place among pancreatic tumors, and that are definitively curable with a multimodal approach. Aim of the book is therefore to get clinicians closer to these pathologies, describing their complexity and the current state of the art in diagnostic, therapeutic and pathological classification strategy, thus providing them with the tools for a modern and updated clinical management of these patients

    Surgery in Italy. Criteria to identify the hospital units and the tertiary referral centers entitled to perform it : A proposal for esophageal, hepatic, pancreatic and colo-rectal surgery

    No full text
    A recent Italian study clearly shows that patients suffering from colorectal liver metastasis and treated in referral Centres receive the “best treatment” with better surgical outcomes and long term survival . Moreover, it is very interesting to note how an inter-hospital network and partnership is able to level the results achieved between higher and lower volume Centres for liver surgery, suggesting the feasibility of accreditation pathway

    Middle Segment Pancreatectomy: A Useful Tool in the Management of Pancreatic Neoplasms

    Full text link
    Small, benign, or low-grade malignant tumors located in the neck of the pancreas are usually treated with enucleation. However, if enucleation is too risky because of possible damage of the main pancreatic duct, standard pancreatic resections are performed. Such operations can lead to impaired long-term exocrine-endocrine function. Middle segment pancreatectomy consists of a limited resection of the midportion of the pancreas and can be performed in selected patients affected by tumors of the pancreatic neck. Middle segment pancreatectomy is a safe and feasible procedure for treating tumors of the pancreatic neck; in experienced hands it is associated with no mortality but with high morbidity, even if the rate of "clinical" pancreatic fistula is about 20\%. Moreover, it allows a surgeon to preserve pancreatic parenchyma and consequently long-term endocrine and exocrine pancreatic function

    Identifying key outcome metrics in pancreatic surgery, and how to optimally achieve them

    No full text
    Background: Indicators of effectiveness and quality of care are of greatest importance in gauging the direct benefit of a new surgical technique, such as minimally-invasive pancreatic resections, when being compared with established approaches.Methods: Current expert opinion on minimally-invasive pancreatic resection (MIPR) was presented at the first MIPR state of the art conference during 12th world congress of the International HepatoPancreato-Biliary Association.Results: Studies exploring outcome of the minimally-invasive approach, alone or compared with open surgery, should consider all the necessary indicators of quality ensuring a high level of clinical care. Such studies should be implemented in a context that guarantees the correct indication for surgery, lower mortality rates, a low burden of post-operative morbidity through early recognition of adverse events and prevention of predictable complications, high standards of oncological "radicality", prompt recovery with access to adjuvant therapy as soon as possible, and reduction of health-care related costs.Discussion: Only by integrating MIPR with the outcome-improving effect of a dedicated pancreatic team will it be possible to assess more precisely the putative benefits of this minimally-invasive approach

    Pancreas: Reconstruction methods after pancreaticoduodenectomy.

    No full text
    Reconstruction methods after pancreaticoduodenectom
    corecore